Skip to main content

Advertisement

Table 4 Response to treatment

From: Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

Response CR PR S P
Number patient (%) 9 (82%) 1 (9%) 0 1 (9%)